CClinicalTrials.gg
Status unknownNCT05230264SSStressAAAUpdated Feb 8, 2022

Sex-specific Differences in the Stress Response to Abdominal Aortic Aneurysm Repair

An observational study in Abdominal Aortic Aneurysm, Stress and Surgery, sponsored by Imperial College London. Status unknown at 1 site in United Kingdom. Open to participants aged 50 Years to 100 Years. Per ClinicalTrials.gov, last updated 2022-02-08.

Sponsored by Imperial College London · Observational

The sponsor has not verified this record recently (last verified Jan 2022), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
60
Ages
50 Years to 100 Years
Sex
All
01

Study summary

It is recognised that women are at greater risk of death, complications and longer hospital stay following intact abdominal aortic aneurysm (AAA) repair, and the reason for this is not yet established. This disparity in outcomes for women compared to men is also recognised in other forms of cardiovascular surgery, which raises the question of whether women and men are reacting differently to the stress of operative repair.

This study aims to examine whether there are differences baseline stress markers and in the stress response to AAA repair between men and women. It will also examine whether markers of stress are associated with poor clinical outcomes and slower recovery (indicated by longer hospital stay).

The study will take the form of an observational cohort study. It will not alter any of the treatment that men and women receive, but will monitor their stress levels using physiological markers (through ECG (electrocardiogram) monitoring using a non-invasive holter, biochemical markers using blood samples (which will be taken at the same time as routine testing, so as not to require further invasive procedures), and psychological testing, using short forms that the patient will be able to fill out independently at different stages of their recovery. Clinical data will be used to look for relevant factors (clinical history or medications) which may alter the stress markers we are observing, and to compare outcomes with markers of stress.

Patients will be asked for their consent to share their data with the research team in order to participate in the study. It will be made clear that there will be no change in their clinical or operative management if they participate in the study and they will be able to withdraw consent for further participation at any time.

02

Conditions studied

  • Abdominal Aortic Aneurysm
  • Stress
  • Surgery
03

In context

Aneurysm

960 studies on the registry are indexed under Aneurysm; 175 are open to participants now.

This study's planned enrollment of 60 is below the median of 151 across 443 observational studies indexed under Aneurysm.

Browse Aneurysm studies →

Lead sponsor

Imperial College London is the lead sponsor of 824 studies on the registry; 178 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 6 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Men and women undergoing primary elective intact AAA repair, open or endovascular (EVAR) at participating centres.

Consecutive recruitment.

Inclusion criteria

  • Men and women undergoing primary elective intact AAA repair, open or endovascular (EVAR) at participating centres.
  • Capacity to consent.

Exclusion criteria

Exclusion Criteria:

  • Participants undergoing a secondary or emergency aortic procedure, or procedure for alternative aortic pathology.
  • Relevant confounding pathology such as hypothalamic-pituitary axis pathology (e.g. Addison's disease).
  • Lack of capacity to consent.
  • Participants with pacemaker dependency, or a significant arrhythmia, will be excluded from analysis of heart rate variability, but will be included in the study for analysis of psychological and biochemical markers of stress.
  • Participants on steroid treatment will also be excluded from analysis of biochemical markers but may be included for analysis of physiological markers and/or heart rate variability.
  • Participants must be over the age of 50 (In order to facilitate capture of degenerative aortic aneurysmal pathology rather than an alternative aortic pathology e.g. traumatic, connective tissue disorder).
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
60 participants (estimated)
Patient registry
No

Groups and cohorts

  • Men

    Elective AAA Repair

    Other: Elective AAA Repair

  • Women

    Elective AAA Repair

    Other: Elective AAA Repair

Interventions

  • OtherElective AAA Repair

    Elective AAA Repair - Observation of Stress Response

06

What researchers measure

Primary outcomes

  1. Biochemical measures of stress: level of serum cortisol & dehydroepiandrosterone (DHEA)

    Sex-specific differences in baseline and timing/magnitude of response to operative stress.

    Time frame: Samples taken on the morning of operation (baseline), at anaesthetic induction, at the end of the procedure, 6 hours post-procedure and early morning samples during the remaining inpatient stay.

Secondary outcomes

  1. Physiological parameters: assessment of beat-to-beat heart rate variability metrics.

    Sex-specific differences in baseline and timing/magnitude of response to operative stress.

    Time frame: Baseline recording compared to post-operative recording of patient recovery during inpatient stay.

  2. Psychological measures of stress: measured by State Trait Anxiety Inventory-Y and self assessment (Likert Scale).

    Sex-specific differences in the baseline and timing/magnitude of response to operative stress.

    Time frame: Pre-operative assessment compared to post-operative assessment at specified intervals during operative recovery - 2, 14, 30 and 90 days post-operation.

07

Study locations

1 site
  • Imperial College London
    London, United Kingdom
    • Colin Bicknell · Contact
    • Anna L Pouncey · Sub investigator
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 8, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05230264
Lead sponsor
Imperial College London
Responsible party
Sponsor
First posted
Feb 8, 2022
Start date
Feb 1, 2022 (estimated)
Primary completion
Oct 1, 2023 (estimated)
Completion
Oct 1, 2023 (estimated)
Last update
Feb 8, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion